Report Summary
Eternity Insights has published a new study on Global Liver Diseases Therapeutics Drugs Market focusing on key segments as by Type (Oral,Injection, Other), by Application (Hospital,Clinic, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Liver Diseases Therapeutics Drugs Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Liver Diseases Therapeutics Drugs Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Liver Diseases Therapeutics Drugs Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Liver Diseases Therapeutics Drugs Market Segmentation:
Liver Diseases Therapeutics Drugs Market, By Type
Liver Diseases Therapeutics Drugs Market, By Application
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Liver Diseases Therapeutics Drugs market in terms of demand generation. The Liver Diseases Therapeutics Drugs market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Liver Diseases Therapeutics Drugs market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Liver Diseases Therapeutics Drugs Market Taxonomy:
To learn more about this report
Global Liver Diseases Therapeutics Drugs Market Competitive Landscape
The global Liver Diseases Therapeutics Drugs market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- F. Hoffmann-La Roche
- Merck
- LG Life Sciences
- Achillion Pharmaceuticals
- Johnson & Johnson
- Angion Biomedica
- Bayer
- AbbVie
- GlaxoSmithKline
- Gilead Sciences
- Verva Pharmaceuticals
- Phenex Pharmaceuticals
- Shenzhen Kangtai Biological Products
- Raptor Pharmaceuticals
- ProMetic Life Sciences
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Oral,Injection, Other |
| By Application Outlook |
Hospital,Clinic, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
F. Hoffmann-La Roche,Merck,LG Life Sciences,Achillion Pharmaceuticals,,Johnson & Johnson,Angion Biomedica,Bayer,AbbVie,GlaxoSmithKline,Gilead Sciences,Verva Pharmaceuticals,Phenex Pharmaceuticals,Shenzhen Kangtai Biological Products,Raptor Pharmaceuticals,ProMetic Life Sciences |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Global Liver Diseases Therapeutics Drugs Industry Market Research Report
1 Liver Diseases Therapeutics Drugs Introduction and Market Overview
1.1 Objectives of the Study
1.2 Definition of Liver Diseases Therapeutics Drugs
1.3 Liver Diseases Therapeutics Drugs Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Liver Diseases Therapeutics Drugs Value ($) and Growth Rate from 2014-2026
1.4 Market Segmentation
1.4.1 Types of Liver Diseases Therapeutics Drugs
1.4.2 Applications of Liver Diseases Therapeutics Drugs
1.4.3 Research Regions
1.4.3.1 North America Liver Diseases Therapeutics Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.2 Europe Liver Diseases Therapeutics Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.3 China Liver Diseases Therapeutics Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.4 Japan Liver Diseases Therapeutics Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.5 Middle East & Africa Liver Diseases Therapeutics Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.6 India Liver Diseases Therapeutics Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.7 South America Liver Diseases Therapeutics Drugs Production Value ($) and Growth Rate (2014-2019)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of Liver Diseases Therapeutics Drugs
1.5.1.2 Growing Market of Liver Diseases Therapeutics Drugs
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
2 Industry Chain Analysis
2.1 Upstream Raw Material Suppliers of Liver Diseases Therapeutics Drugs Analysis
2.2 Major Players of Liver Diseases Therapeutics Drugs
2.2.1 Major Players Manufacturing Base and Market Share of Liver Diseases Therapeutics Drugs in 2018
2.2.2 Major Players Product Types in 2018
2.3 Liver Diseases Therapeutics Drugs Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Liver Diseases Therapeutics Drugs
2.3.3 Raw Material Cost of Liver Diseases Therapeutics Drugs
2.3.4 Labor Cost of Liver Diseases Therapeutics Drugs
2.4 Market Channel Analysis of Liver Diseases Therapeutics Drugs
2.5 Major Downstream Buyers of Liver Diseases Therapeutics Drugs Analysis
3 Global Liver Diseases Therapeutics Drugs Market, by Type
3.1 Global Liver Diseases Therapeutics Drugs Value ($) and Market Share by Type (2014-2019)
3.2 Global Liver Diseases Therapeutics Drugs Production and Market Share by Type (2014-2019)
3.3 Global Liver Diseases Therapeutics Drugs Value ($) and Growth Rate by Type (2014-2019)
3.4 Global Liver Diseases Therapeutics Drugs Price Analysis by Type (2014-2019)
4 Liver Diseases Therapeutics Drugs Market, by Application
4.1 Global Liver Diseases Therapeutics Drugs Consumption and Market Share by Application (2014-2019)
4.2 Downstream Buyers by Application
4.3 Global Liver Diseases Therapeutics Drugs Consumption and Growth Rate by Application (2014-2019)
5 Global Liver Diseases Therapeutics Drugs Production, Value ($) by Region (2014-2019)
5.1 Global Liver Diseases Therapeutics Drugs Value ($) and Market Share by Region (2014-2019)
5.2 Global Liver Diseases Therapeutics Drugs Production and Market Share by Region (2014-2019)
5.3 Global Liver Diseases Therapeutics Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.4 North America Liver Diseases Therapeutics Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.5 Europe Liver Diseases Therapeutics Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.6 China Liver Diseases Therapeutics Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.7 Japan Liver Diseases Therapeutics Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.8 Middle East & Africa Liver Diseases Therapeutics Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.9 India Liver Diseases Therapeutics Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.10 South America Liver Diseases Therapeutics Drugs Production, Value ($), Price and Gross Margin (2014-2019)
6 Global Liver Diseases Therapeutics Drugs Production, Consumption, Export, Import by Regions (2014-2019)
6.1 Global Liver Diseases Therapeutics Drugs Consumption by Regions (2014-2019)
6.2 North America Liver Diseases Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)
6.3 Europe Liver Diseases Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)
6.4 China Liver Diseases Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)
6.5 Japan Liver Diseases Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)
6.6 Middle East & Africa Liver Diseases Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)
6.7 India Liver Diseases Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)
6.8 South America Liver Diseases Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)
7 Global Liver Diseases Therapeutics Drugs Market Status and SWOT Analysis by Regions
7.1 North America Liver Diseases Therapeutics Drugs Market Status and SWOT Analysis
7.2 Europe Liver Diseases Therapeutics Drugs Market Status and SWOT Analysis
7.3 China Liver Diseases Therapeutics Drugs Market Status and SWOT Analysis
7.4 Japan Liver Diseases Therapeutics Drugs Market Status and SWOT Analysis
7.5 Middle East & Africa Liver Diseases Therapeutics Drugs Market Status and SWOT Analysis
7.6 India Liver Diseases Therapeutics Drugs Market Status and SWOT Analysis
7.7 South America Liver Diseases Therapeutics Drugs Market Status and SWOT Analysis
8 Competitive Landscape
8.1 Competitive Profile
8.2 F. Hoffmann-La Roche
8.2.1 Company Profiles
8.2.2 Liver Diseases Therapeutics Drugs Product Introduction
8.2.3 F. Hoffmann-La Roche Production, Value ($), Price, Gross Margin 2014-2019
8.2.4 F. Hoffmann-La Roche Market Share of Liver Diseases Therapeutics Drugs Segmented by Region in 2018
8.3 Merck
8.3.1 Company Profiles
8.3.2 Liver Diseases Therapeutics Drugs Product Introduction
8.3.3 Merck Production, Value ($), Price, Gross Margin 2014-2019
8.3.4 Merck Market Share of Liver Diseases Therapeutics Drugs Segmented by Region in 2018
8.4 LG Life Sciences
8.4.1 Company Profiles
8.4.2 Liver Diseases Therapeutics Drugs Product Introduction
8.4.3 LG Life Sciences Production, Value ($), Price, Gross Margin 2014-2019
8.4.4 LG Life Sciences Market Share of Liver Diseases Therapeutics Drugs Segmented by Region in 2018
8.5 Achillion Pharmaceuticals,
8.5.1 Company Profiles
8.5.2 Liver Diseases Therapeutics Drugs Product Introduction
8.5.3 Achillion Pharmaceuticals, Production, Value ($), Price, Gross Margin 2014-2019
8.5.4 Achillion Pharmaceuticals, Market Share of Liver Diseases Therapeutics Drugs Segmented by Region in 2018
8.6 Johnson & Johnson
8.6.1 Company Profiles
8.6.2 Liver Diseases Therapeutics Drugs Product Introduction
8.6.3 Johnson & Johnson Production, Value ($), Price, Gross Margin 2014-2019
8.6.4 Johnson & Johnson Market Share of Liver Diseases Therapeutics Drugs Segmented by Region in 2018
8.7 Angion Biomedica
8.7.1 Company Profiles
8.7.2 Liver Diseases Therapeutics Drugs Product Introduction
8.7.3 Angion Biomedica Production, Value ($), Price, Gross Margin 2014-2019
8.7.4 Angion Biomedica Market Share of Liver Diseases Therapeutics Drugs Segmented by Region in 2018
8.8 Bayer
8.8.1 Company Profiles
8.8.2 Liver Diseases Therapeutics Drugs Product Introduction
8.8.3 Bayer Production, Value ($), Price, Gross Margin 2014-2019
8.8.4 Bayer Market Share of Liver Diseases Therapeutics Drugs Segmented by Region in 2018
8.9 AbbVie
8.9.1 Company Profiles
8.9.2 Liver Diseases Therapeutics Drugs Product Introduction
8.9.3 AbbVie Production, Value ($), Price, Gross Margin 2014-2019
8.9.4 AbbVie Market Share of Liver Diseases Therapeutics Drugs Segmented by Region in 2018
8.10 GlaxoSmithKline
8.10.1 Company Profiles
8.10.2 Liver Diseases Therapeutics Drugs Product Introduction
8.10.3 GlaxoSmithKline Production, Value ($), Price, Gross Margin 2014-2019
8.10.4 GlaxoSmithKline Market Share of Liver Diseases Therapeutics Drugs Segmented by Region in 2018
8.11 Gilead Sciences
8.11.1 Company Profiles
8.11.2 Liver Diseases Therapeutics Drugs Product Introduction
8.11.3 Gilead Sciences Production, Value ($), Price, Gross Margin 2014-2019
8.11.4 Gilead Sciences Market Share of Liver Diseases Therapeutics Drugs Segmented by Region in 2018
8.12 Verva Pharmaceuticals
8.12.1 Company Profiles
8.12.2 Liver Diseases Therapeutics Drugs Product Introduction
8.12.3 Verva Pharmaceuticals Production, Value ($), Price, Gross Margin 2014-2019
8.12.4 Verva Pharmaceuticals Market Share of Liver Diseases Therapeutics Drugs Segmented by Region in 2018
8.13 Phenex Pharmaceuticals
8.13.1 Company Profiles
8.13.2 Liver Diseases Therapeutics Drugs Product Introduction
8.13.3 Phenex Pharmaceuticals Production, Value ($), Price, Gross Margin 2014-2019
8.13.4 Phenex Pharmaceuticals Market Share of Liver Diseases Therapeutics Drugs Segmented by Region in 2018
8.14 Shenzhen Kangtai Biological Products
8.14.1 Company Profiles
8.14.2 Liver Diseases Therapeutics Drugs Product Introduction
8.14.3 Shenzhen Kangtai Biological Products Production, Value ($), Price, Gross Margin 2014-2019
8.14.4 Shenzhen Kangtai Biological Products Market Share of Liver Diseases Therapeutics Drugs Segmented by Region in 2018
8.15 Raptor Pharmaceuticals
8.15.1 Company Profiles
8.15.2 Liver Diseases Therapeutics Drugs Product Introduction
8.15.3 Raptor Pharmaceuticals Production, Value ($), Price, Gross Margin 2014-2019
8.15.4 Raptor Pharmaceuticals Market Share of Liver Diseases Therapeutics Drugs Segmented by Region in 2018
8.16 ProMetic Life Sciences
8.16.1 Company Profiles
8.16.2 Liver Diseases Therapeutics Drugs Product Introduction
8.16.3 ProMetic Life Sciences Production, Value ($), Price, Gross Margin 2014-2019
8.16.4 ProMetic Life Sciences Market Share of Liver Diseases Therapeutics Drugs Segmented by Region in 2018
9 Global Liver Diseases Therapeutics Drugs Market Analysis and Forecast by Type and Application
9.1 Global Liver Diseases Therapeutics Drugs Market Value ($) & Volume Forecast, by Type (2019-2026)
9.1.1 Oral Market Value ($) and Volume Forecast (2019-2026)
9.1.2 Injection Market Value ($) and Volume Forecast (2019-2026)
9.2 Global Liver Diseases Therapeutics Drugs Market Value ($) & Volume Forecast, by Application (2019-2026)
9.2.1 Hospital Market Value ($) and Volume Forecast (2019-2026)
9.2.2 Clinic Market Value ($) and Volume Forecast (2019-2026)
10 Liver Diseases Therapeutics Drugs Market Analysis and Forecast by Region
10.1 North America Market Value ($) and Consumption Forecast (2019-2026)
10.2 Europe Market Value ($) and Consumption Forecast (2019-2026)
10.3 China Market Value ($) and Consumption Forecast (2019-2026)
10.4 Japan Market Value ($) and Consumption Forecast (2019-2026)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2019-2026)
10.6 India Market Value ($) and Consumption Forecast (2019-2026)
10.7 South America Market Value ($) and Consumption Forecast (2019-2026)
11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 Research Finding and Conclusion
13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used
